Salarius Pharmaceuticals Files Preliminary Proxy Statement
Ticker: DCOY · Form: DEF 14A · Filed: May 15, 2025 · CIK: 1615219
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, annual-meeting
TL;DR
Salarius Pharma filed its proxy statement, no fee needed. Annual meeting details coming soon.
AI Summary
Salarius Pharmaceuticals, Inc. filed a preliminary proxy statement on May 15, 2025, for its annual meeting. The filing indicates no fee was required for this submission. The company, formerly known as Flex Pharma, Inc., is based in Houston, Texas, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing is a routine step for public companies to inform shareholders about upcoming meetings and matters to be voted on, such as director elections and executive compensation.
Risk Assessment
Risk Level: low — This is a standard regulatory filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- Flex Pharma, Inc. (company) — Former company name
- 20250515 (date) — Filing date
FAQ
What is the purpose of this DEF 14A filing?
This filing is a preliminary proxy statement filed by Salarius Pharmaceuticals, Inc. pursuant to Section 14(a) of the Securities Exchange Act of 1934, to provide information to shareholders regarding its annual meeting.
When was this filing submitted?
The filing was submitted on May 15, 2025.
Was a fee required for this filing?
No, the filing indicates that no fee was required for this submission.
What was Salarius Pharmaceuticals, Inc. formerly known as?
Salarius Pharmaceuticals, Inc. was formerly known as Flex Pharma, Inc., with a name change date of July 30, 2014.
Where is Salarius Pharmaceuticals, Inc. located?
The company's business and mailing address is 2450 Holcombe Blvd, Suite J-608, Houston, TX 77021.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 15, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).